TNF and juvenile idiopathic arthritis: Thus, anti-TNF-α monoclonal antibodies are broadly used and are efficient in particular for the treatment of rheumatoid arthritis (RA), inflammatory bowel disease (IBD), psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), and juvenile idiopathic arthritis (JIA) [2].